Myolex

Myolex® is disrupting how to measure muscle wasting (and treatment), caused by obesity drugs, aging, and sport injuries.

General Information
Company Name
Myolex
Founded Year
2009
Location (Offices)
Brookline, United States +1
Founders / Decision Makers
Number of Employees
10
Industries
Health Care, Health and Wellness, Medical Devices
Funding Stage
-
Social Media

Myolex - Company Profile

Myolex is a cutting-edge health care startup based in the United States, founded in 2009. The company's slogan is "Myolex® is building the new clinical standard to aid in the diagnosis and monitoring of skeletal muscle diseases." Myolex® aims to revolutionize the diagnosis and monitoring of neuromuscular disorders and muscle wasting diseases through their patented electrical impedance myography (EIM) technology, originally developed by co-founder Dr. Seward Rutkove, a prominent figure in the medical field.Myolex's mScan research device and data analytics platform represent a significant advancement, providing a quantitative, comprehensive, and portable solution to monitor and display the bioimpedance of muscle. Their technology not only holds the potential to reduce drug clinical trial costs and aid in early disease diagnosis but also to replace expensive and non-portable muscle measurement devices like MRI for specific muscle groups.The extensive research and patents backing Myolex's technology, along with its potential to revolutionize muscle disease diagnostics and patient care, make it an attractive prospect for venture capital investment. The company's commitment to addressing critical medical needs and enhancing patient outcomes positions it as a promising opportunity for investors seeking impactful healthcare innovations.

Taxonomy: Muscle Assessment, Neuromuscular Disorders, Clinical Research, Electrical Impedance Myography (EIM), Medical Innovation, Diagnostic Tools, Data Analytics Platform, Patented Technology, Portable Medical Devices

Funding Rounds & Investors of Myolex (0)

View All

There is no investment information

Latest News of Myolex

View All

No recent news or press coverage available for Myolex.

Similar Companies to Myolex

View All
Immunis, Inc. - Similar company to Myolex
Immunis, Inc. Developing innovative, stem cell-derived secretome therapies to reverse age-related diseases and immune dysfunction.
Morphic Medical - Similar company to Myolex
Morphic Medical Innovative therapies for type 2 diabetes and obesity, rooted in excellence since 2003.
Muscular Dystrophy UK - Similar company to Myolex
Muscular Dystrophy UK We’re here for everyone living with and affected by muscle wasting and weakening conditions.
MyoPax - Similar company to Myolex
MyoPax the vanguard in cell and gene therapies for muscle disorders